Provided by Tiger Trade Technology Pte. Ltd.

Sight Sciences, Inc.

3.88
-0.1200-3.00%
Post-market: 3.900.0200+0.52%17:28 EDT
Volume:250.29K
Turnover:975.56K
Market Cap:209.54M
PE:-5.24
High:3.96
Open:3.94
Low:3.83
Close:4.00
52wk High:9.24
52wk Low:2.03
Shares:54.01M
Float Shares:28.82M
Volume Ratio:0.80
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7400
EPS(LYR):-0.7369
ROE:-50.74%
ROA:-16.61%
PB:3.28
PE(LYR):-5.27

Loading ...

Top Brass at Sight Sciences Quietly Cashes In With Major Stock Disposals

TIPRANKS
·
Jan 22

Sight Sciences CEO Paul Badawi Reports Sale of Common Shares

Reuters
·
Jan 22

Sight Sciences, Inc.'s (NASDAQ:SGHT) 26% Share Price Plunge Could Signal Some Risk

Simply Wall St.
·
Jan 21

Sight Sciences Falls on Expected FY Revenue Decline

Dow Jones
·
Jan 14

Sight Sciences Reports Preliminary Q4 Revenue

MT Newswires Live
·
Jan 14

Lake Street Reaffirms Their Buy Rating on Sight Sciences (SGHT)

TIPRANKS
·
Jan 13

BRIEF-Sight Sciences Announces Preliminary, Unaudited Fourth Quarter And Full Year 2025 Financial Highlights

Reuters
·
Jan 13

Sight Sciences Inc Q4 REV View $20.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 13

Press Release: Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights

Dow Jones
·
Jan 13

Sight Sciences Shares Rise After Piper Sandler Upgrade

MT Newswires Live
·
Jan 06

Sight Sciences Raised to Overweight From Neutral by Piper Sandler

Dow Jones
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Liberty Energy, Fortive

Reuters
·
Jan 05

Piper Sandler Upgrades Sight Sciences to Overweight From Neutral, Adjusts Price Target to $9 From $5

MT Newswires Live
·
Jan 05

BUZZ-Piper Sandler upgrades Sight Sciences on strong business prospects

Reuters
·
Jan 05

Sight Sciences Is Maintained at Buy by UBS

Dow Jones
·
Dec 23, 2025

Director Staffan Encrantz Reports Acquisition of Sight Sciences Inc. Common Shares

Reuters
·
Dec 19, 2025

Sight Sciences Is Maintained at Neutral by Citigroup

Dow Jones
·
Dec 12, 2025

Sight Sciences Is Maintained at Buy by Lake Street

Dow Jones
·
Dec 11, 2025

Sight Sciences Q3 Revenue USD 19.9 Million Vs. IBES Estimate USD 17.7 Million

Reuters
·
Nov 20, 2025

New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans

GlobeNewswire
·
Nov 11, 2025